July 17, 2023
After a weeklong trial, a jury in Wilmington, Delaware, decided that Abbott's diabetes unit already has a license to four claims in a patent issued to a longtime rival, but does not have a license to 13 other claims — laying the groundwork for a further jury trial to deal with infringement allegations.